Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk. J Infect Dis. 2002 Oct 15;186(8):1173-6

dc.contributor.author	Farquhar, C.
dc.contributor.author	VanCott, T.C.
dc.contributor.author	Mbori-Ngacha, D.A.
dc.contributor.author	Horani, L.
dc.contributor.author	Bosire, RK
dc.date.accessioned	2013-07-10T14:19:55Z
dc.date.available	2013-07-10T14:19:55Z
dc.date.issued	2002
dc.identifier.citation	MBORI-, PROFNGACHADOROTHYA. 2002. Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk. J Infect Dis. 2002 Oct 15;186(8):1173-6. Farquhar C, VanCott TC,Mbori-Ngacha DA, Horani L, Bosire RK, Kreis. Infect Dis. 2002 Oct 15;186(8):1173-6.. : Earthscan, London. 978-1-84407-469-3	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/47159
dc.description.abstract	No abstract available	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk. J Infect Dis. 2002 Oct 15;186(8):1173-6	en
dc.type	Article	en

Files in this item

Files	Size	Format	View
There are no files associated with this item.